Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
0.3140
-0.0050 (-1.57%)
At close: Sep 11, 2026, 4:00 PM EDT
0.3150
+0.0010 (0.32%)
After-hours: Sep 11, 2026, 7:52 PM EDT
Jaguar Health Employees
Jaguar Health had 47 employees as of December 31, 2025. The number of employees decreased by 2 or -4.08% compared to the previous year.
Employees
47
Change (1Y)
-2
Growth (1Y)
-4.08%
Revenue / Employee
$591,809
Profits / Employee
-$1,115,319
Market Cap
1.62M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 47 | -2 | -4.08% |
| Dec 31, 2024 | 49 | 0 | - |
| Dec 31, 2023 | 49 | -11 | -18.33% |
| Dec 31, 2022 | 60 | 8 | 15.38% |
| Dec 31, 2021 | 52 | 18 | 52.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Virax Biolabs Group | 26 |
| Curis | 24 |
| Silexion Therapeutics | 14 |
| Decoy Therapeutics | 11 |
| Jupiter Neurosciences | 5 |
| Oragenics | 3 |
| Propanc Biopharma | 2 |
JAGX News
- 2 days ago - Jaguar Health announces all pediatric MVID patients entered extension phase - TheFly
- 2 days ago - All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF) - Accesswire
- 4 days ago - Jaguar Health announces Neonorm Dog availability on Amazon - TheFly
- 8 days ago - Jaguar Health reports additional infant patient to receive crofelemer for IF - TheFly
- 8 days ago - Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) - Accesswire
- 17 days ago - Jaguar Health initiated commercial launch of Neonorm Dog - TheFly
- 17 days ago - Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs - Accesswire
- 24 days ago - Jaguar Health Transcript: Investor update - Transcripts